STACY SLADE: Open Payments
NPI 1669996567 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$997 in 41 payments from 15 companies in 2025. Trend: 2023 $1,653 · 2024 $1,480 · 2025 $997
Food & beverage: $997
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 7 | $170 |
| ABBVIE INC. | 6 | $139 |
| Boston Scientific Corporation | 2 | $128 |
| Antares Pharma, Inc. | 6 | $95 |
| ACCORD HEALTHCARE, INC. | 4 | $85 |
| PFIZER INC. | 3 | $60 |
| UROGEN PHARMA, INC. | 2 | $56 |
| Janssen Biotech, Inc. | 2 | $55 |
| Myriad Genetic Laboratories, Inc. | 1 | $50 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $41 |
Products named: BOTOX, General - Erectile Dysfunction, XYOSTED, GEMTESA, Camcevi, ORGOVYX, XTANDI, ERLEADA.
Industry payments across NV — which companies pay providers there.
